ISPOR EU 2023
As stakeholder engagement becomes increasingly science-based and evidence-driven, generating actionable evidence – especially RWE and HEOR data – in a timely manner has become more important than ever. Further, the ability to anticipate, shape, and optimize product development has become one of the most critical success factors for realizing an innovation’s full promise.
Syneos Health will be joining thousands of healthcare leaders at ISPOR’s global event on key health economics and outcomes research (HEOR) topics.
Our team of experts will be on the floor at ISPOR EU 2023 to discuss RWE and HEOR strategies that can optimize your asset’s value story, and lead to greater clinical and commercial success and improved patient outcomes.
Find us at Booth C3-118 or schedule a meeting to discuss your pressing evidence challenges.
Featured Presentations
Issue Panel: Use of External Control Arms in Rare Disease: Are We Moving Towards an International Gold Standardand How Can We Facilitate Progress?
November 14 | 13:45-14:45
Moderator: Carla Vossen, PhD, Senior Director, Epidemiology & RWE
Panel: The Role of Artificial Intelligence: From Economic Modelling to Clinical Decision Making
November 14 | 13:45-14:45
Moderator: Erwin De Cock, MSc, Executive Director, Real World and Late Phase
Workshop: External Control Arm Planning for Rare Diseases
November 14 | 17:00-18:00
Discussion Leader: Raymond Huml, VP, Medical and Scientific Strategy and Head, Rare Disease Consortium
Discussant: Carla Vossen, PhD, Senior Director, Epidemiology & RWE
Featured Research Posters:
Disease Diagnosis and Severity Prediction: Artificial Intelligence Applications in Hemophilia A DOWNLOAD
Exploring Respiratory Syncytial Virus and Influenza Trends Pre- and Post-COVID-19 in the US and EU-5 Countries DOWNLOAD
Real-World Treatment Patterns for Acute Lymphoblastic Leukemia Utilizing Claims Data DOWNLOAD
The Socio- Economic burden on Caregivers of Pediatric Autistic Population in Europe: A Systematic Review DOWNLOAD
Patient Data Use in Medical Research Vs Data Privacy: Perspective from Five Patient Association Representatives DOWNLOAD
Additional Resources:
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
Capabilities
Syneos Health Medical Affairs
Real World and Late Phase at Syneos Health
Health Economics and Outcomes Research (HEOR)
Insights
Exploring Real World Evidence Across Medical Landscapes for ICPE 202
RWE, RWD and Tokenization for Asset Development: What Biopharma Teams Need to Know
Building a Market Access Case for Real World Evidence in Oncology
Success Factors in Long-Term Follow-Up Studies
Amplifying the Synergy Between Medical Affairs and Clinical Development
Syneos Health Podcast: Medical Affairs Series
Syneos Health Podcast: The Value of Registries
